This inventor holds 7 USPTO granted patents. Top assignees: Ajinomoto Co., Ltd., Mochida Pharmaceutical Co., Ltd.. Active years: 1987-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1987-2002
Title: Hirokazu Naora: Innovator in Piperidine Derivatives
Introduction
Hirokazu Naora is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of chemistry, particularly in the development of piperidine derivatives. With a total of 7 patents to his name, Naora's work has had a substantial impact on pharmaceutical research and development.
Latest Patents
Naora's latest patents include innovative processes and compounds. One notable patent is for the "Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same." This patent focuses on monohydrate and trihydrate crystals of N-(2-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-piperidino) ethyl)-1-formyl-4-piperidinecarboxamide hydrochloride, which exhibits excellent stability. Another significant patent is for a "Process for producing piperidinecarboxylic acid amide derivatives." This process is designed to produce derivatives that are useful as serotonin antagonists and antithrombocytic agents, showcasing its industrial applicability.
Career Highlights
Throughout his career, Hirokazu Naora has worked with notable companies such as Ajinomoto Co., Ltd. and Mochida Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in chemical processes and pharmaceutical applications.
Collaborations
Naora has collaborated with esteemed colleagues, including Jiro Shimada and Tomoya Yamamoto. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Hirokazu Naora's innovative work in the field of piperidine derivatives has established him as a key figure in pharmaceutical chemistry. His patents reflect a commitment to advancing medical science and improving therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile